BFC Planning’s Connect Biopharma Holdings CNTB Stock Holding History
Bought
Maintained
Sold
Other funds holding CNTB
BCM
DMKJ
BFC Planning's CNTB Position: Q3 2026 in Review
BFC Planning held its Connect Biopharma Holdings (CNTB) position steady in Q3 2026 at 400 shares worth $440. The position accounts for ﹤0.01% of the portfolio, ranked #3301.
BFC Planning first reported a position in CNTB in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.41K in Q4 2025. 42 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.
- BFC Planning held 400 shares of Connect Biopharma Holdings worth $440 as of Q3 2026.
- BFC Planning left its Connect Biopharma Holdings share count unchanged in Q3 2026.
- Connect Biopharma Holdings made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3301 holding.
- BFC Planning first reported a position in Connect Biopharma Holdings in Q3 2025 and has held it in 5 quarters since.
- BFC Planning's Connect Biopharma Holdings position peaked at $1.41K in Q4 2025.
- 42 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.